Related Articles
Successful personalized chemotherapy for metastatic gastric cancer based on quantitative BRCA1 mRNA expression level: A case report
Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer
The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells
The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin‑based adjuvant chemotherapy
Growth and molecular interactions of the anti-EGFR antibody Cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: New prospects in the treatment of triple-negative/basal-like breast cancer